This study demonstrated a new role for LTB4 as a negative regulator at a key point of TGF-β1 signaling necessary for growth inhibition, and revealed that blockade of BLT1 expression sensitizes breast cancer cells to TGF-β1-induced growth inhibition both in vitro and in vivo. The gene discussed is LTB4R; the disease is breast cancer.